Down syndrome, autoimmunity and T regulatory cells

Clinical and Experimental Immunology

Volumn 169, Issue 3, 2012, Pages 238-243

  Pellegrini, F P ^a   Marinoni, M ^a   Frangione, V ^a   Tedeschi, A ^a   Gandini, V ^a   Ciglia, F ^a   Mortara, L ^a   Accolla, R S ^a   Nespoli, L ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Autoimmunity; Coeliac disease; Down syndrome; Hashimoto disease; Regulatory T cells

Indexed keywords

T LYMPHOCYTE ANTIBODY; TRANSCRIPTION FACTOR FOXP3;

ADOLESCENT; ADULT; ARTICLE; ATOPY; AUTOIMMUNITY; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELIAC DISEASE; CHILD; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; MALE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; VITILIGO;

ADOLESCENT; ANTIGENS, CD; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; COCULTURE TECHNIQUES; DOWN SYNDROME; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENETIC PREDISPOSITION TO DISEASE; HASHIMOTO DISEASE; HUMANS; IMMUNE TOLERANCE; INFANT; LYMPHOCYTE COUNT; MALE; STROMAL CELLS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND; YOUNG ADULT;

EID: 84864766776     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2012.04610.x     Document Type: Article

References (44)

1. Carnicer J, Farré C, Varea V, Vilar P, Moreno J, Artigas J. Prevalence of coeliac disease in Down's syndrome. Eur J Gastroenterol Hepatol 2001; 13:263-67.
2. Anwar AJ, Walker JD, Frier BM. Type 1 Diabetes mellitus and Down's syndrome: prevalence, management and diabetic complications. Diabet Med 1998; 15:160-63.
3. American Academy of Pediatrics Committee on Genetics. Health supervision for children with Down syndrome. Pediatrics 2001; 107:442-49.
4. Epstein CJ, Korenberg JR, Annerén G etal. Protocols to establish genotype-phenotype correlations in Down syndrome. Am J Hum Genet 1991; 49:207-35.
5. Reymond A, Marigo V, Yaylaoglu MB etal. Human chromosome 21 gene expression atlas in the mouse. Nature 2002; 420:582-6.
6. Lyle R, Béna F, Gagos S etal. Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21. Eur J Hum Genet 2009; 17:454-66.
7. Yang Q, Rasmussen SA, Friedman JM. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet 2002; 359:1019-25.
8. Garrison MM, Jeffries H, Christakis DA. Risk of death for children with Down syndrome and sepsis. J Pediatr 2005; 147:748-52.
9. Burgio GR, Ugazio AG, Nespoli L, Marcioni AF, Bottelli AM, Pasquali F. Derangements of immunoglobulin levels, phytohemagglutinin responsiveness and T and B cell markers in Down's syndrome at different ages. Eur J Immunol 1975; 5:600-3.
10. Ram G, Chinen J. Infections and immunodeficiency in Down syndrome. Clin Exp Immunol 2011; 164:9-16.
11. Levin S, Schlesinger M, Handzel Z etal. Thymic deficiency in Down's syndrome. Pediatrics 1979; 63:80-3.
12. Murphy M, Friend DS, Pike-Nobile L, Epstein LB. Tumor necrosis factor alpha and IFN-gamma expression in human thymus. J Immunol 1992; 149:2506-12.
13. Murphy M, Insoft RM, Pike-Nobile L, Epstein LB. A hypothesis to explain the immune defects in Down syndrome. Prog Clin Biol Res 1995; 393:147-67.
14. Sakaguchi S, Tanaka S, Tanaka A etal. Thymus, innate immunity and autoimmune arthritis: interplay of gene and environment. FEBS Lett 2011; 585:3633-9.
15. Bayer AL, Lee JY, de la Barrera A, Surh CD, Malek TR. A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells. J Immunol 2008; 181:225-34.
16. Ziegler SF, Liu YJ. Thymic stromal lymphopoietin in normal and pathogenic T cell development and function. Nat Immunol 2006; 7:709-14.
17. Jiang Q, Su H, Knudsen G, Helms W, Su L. Delayed functional maturation of natural regulatory T cells in the medulla of postnatal thymus: role of TSLP. BMC Immunol 2006; 7:6.
18. Watanabe N, Wang YH, Lee HK etal. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 2005; 436:1181-5.
19. Wong J, Mathis D, Benoist C. TCR-based lineage tracing: no evidence for conversion of conventional into regulatory T cells in response to a natural self-antigen in pancreatic islets. J Exp Med 2007; 204:2039-45.
20. Murphy M, Lempert MJ, Epstein LB. Decreased level of T cell receptor expression by Down syndrome (trisomy 21) thymocytes. Am J Med Genet 1999; 7:234-7.
21. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22:531-62.
22. Haribhai D, Williams JB, Jia S etal. A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity 2011; 35:109-22.
23. Hsieh CS, Zheng Y, Liang Y, Fontenot JD, Rudensky AY. An intersection between the self-reactive regulatory and non-regulatory T cell receptor repertoires. Nat Immunol 2006; 7:401-10.
24. Pacholczyk R, Ignatowicz H, Kraj P, Ignatowicz L. Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells. Immunity 2006; 25:249-59.
25. Benson A, Murray S, Divakar P etal. Microbial infection-induced expansion of effector T cells overcomes the suppressive effects of regulatory T cells via an IL-2 deprivation mechanism. J Immunol 2012; 188:800-10.
26. Adeegbe D, Matsutani T, Yang J, Altman NH, Malek TR. CD4(+) CD25(+) Foxp3(+) T regulatory cells with limited TCR diversity in control of autoimmunity. J Immunol 2010; 184:56-66.
27. Malek TR, Pugliese A. Low-dose IL-2 as a therapeutic agent for tolerance induction. Immunotherapy 2011; 3:1281-4.
28. Liu W, Putnam AL, Xu-Yu Z etal. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ Treg cells. J Exp Med 2006; 203:1701-11.
29. Roat E, Prada N, Lugli E etal. Homeostatic cytokines and expansion of regulatory T cells accompany thymic impairment in children with Down syndrome. Rejuvenation Res 2008; 11:573-83.
30. Shield JPH, Wadsworth EJ, Hassold TJ, Judis LA, Jacobs PA. Is disomic homozygosity at the APECED locus the cause of increased autoimmunity in Down's syndrome? Arch Dis Child 1999; 81:147-50.
31. Cuadrado E, Barrena MJ. Immune dysfunction in Down's syndrome: primary immunodeficiency or early senescence of the immune system? Clin Immunol Immunopathol 1996; 78:209-14.
32. Buckner JH. Mechanism of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases. Nat Rev Immunol 2010; 10:849-59.
33. Bennett CL, Christie J, Ramsdell F etal. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27:20-1.
34. Cassani B, Poliani PL, Moratto D etal. Defect of regulatory T cells in patients with Omenn syndrome. J Allergy Clin Immunol 2010; 125:209-16.
35. Bloemers BL, Bont L, de Weger RA, Otto SA, Borghans JA, Tesselaar K. Decreased thymic output accounts for decreased naive T cell numbers in children with Down syndrome. J Immunol 2011; 186:4500-7.
36. Knutsen AP, Baker MW, Markert ML. Interpreting low T-cell receptor excision circles in newborns with DiGeorge anomaly: importance of assessing naive T-cell markers. J Allergy Clin Immunol 2011; 128:1375-6.
37. Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010; 10:490-500.
38. Passerini L, Olek S, Di Nunzio S etal. Forkhead box protein 3 (FOXP3) mutations lead to increased TH17 cell numbers and regulatory T-cell instability. J Allergy Clin Immunol 2011; 128:1376-9.
39. Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 2009; 10:595-602.
40. Zheng Y, Chaudhry A, Kas A etal. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control Th2 responses. Nature 2009; 458:351-6.
41. Kwon H, Thierry-Mieg D, Thierry-Mieg J etal. Analysis of interleukin-21-induced Prdm 1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity 2009; 31:941-52.
42. + regulatory T cells. Nat Rev Immunol 2011; 11:119-30.
43. Kaminitz A, Yolcu ES, Stein J, Yaniv I, Shirwan H, Askenasy N. Killer Treg restore immune homeostasis and suppress autoimmune diabetes in prediabetic NOD mice. J Autoimmun 2011; 37:39-47.
44. Roizen NJ, Patterson D. Down's syndrome. Lancet 2003; 361:1281-9.